ARCHIVES

DCBD Board Okays Concept For New Cytogenetics RFA

This article is from The Cancer Letter archive.

Vol. 10 No. 31 | August 3, 1984

Download PDF Visit The Full Archive

Related Articles

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975